Bertz J, Hentschel S, Hundsdörfer G, Kaatsch P, Katalinic A, Lehnert M, Schön D, Stegmaier C, Ziegler H: Krebs in Deutschland. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland. 2004,4. aktualisierte Ausgabe,
Google Scholar
Carter HB, Isaacs WB: Improved biomarkers for prostate cancer: a definite need. J Natl Cancer Inst. 2004, 96 (11): 813-815.
Article
PubMed
Google Scholar
Srigley JR, Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W, Wheeler TM, Montironi R: Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives. Scand J Urol Nephrol Suppl. 2005, (216): 8-19.
Fournier G, Valeri A, Mangin P, Cussenot O: [Prostate cancer. Epidemiology. Risk factors. Pathology]. Ann Urol (Paris). 2004, 38 (5): 187-206.
Article
CAS
Google Scholar
Khan MA, Partin AW: Surgical margin status after radical retropubic prostatectomy. BJU Int. 2005, 95 (3): 281-284. 10.1111/j.1464-410X.2005.05282.x.
Article
PubMed
Google Scholar
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002, 419 (6907): 624-629. 10.1038/nature01075.
Article
CAS
PubMed
Google Scholar
Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, Chinnaiyan AM: Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 2001, 61 (20): 7585-7593.
CAS
PubMed
Google Scholar
Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M, Rosenthal A: Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol. 2005, 205 (3): 359-376. 10.1002/path.1676.
Article
CAS
PubMed
Google Scholar
Kristiansen G, Pilarsky C, Pervan J, Sturzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M: CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate. 2004, 58 (2): 183-192. 10.1002/pros.10324.
Article
PubMed
Google Scholar
Pirruccello SJ, LeBien TW: The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol. 1986, 136 (10): 3779-3784.
CAS
PubMed
Google Scholar
Fogel M, Friederichs J, Zeller Y, Husar M, Smirnov A, Roitman L, Altevogt P, Sthoeger ZM: CD24 is a marker for human breast carcinoma. Cancer Lett. 1999, 143 (1): 87-94. 10.1016/S0304-3835(99)00195-0.
Article
CAS
PubMed
Google Scholar
Huang LR, Hsu HC: Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res. 1995, 55 (20): 4717-4721.
CAS
PubMed
Google Scholar
Jackson D, Waibel R, Weber E, Bell J, Stahel RA: CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res. 1992, 52 (19): 5264-5270.
CAS
PubMed
Google Scholar
Senner V, Sturm A, Baur I, Schrell UH, Distel L, Paulus W: CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol. 1999, 58 (8): 795-802.
Article
CAS
PubMed
Google Scholar
Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G: Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol Oncol. 2005, 97 (2): 379-386. 10.1016/j.ygyno.2005.01.018.
Article
CAS
PubMed
Google Scholar
Liu W, Vadgama JV: Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells. Int J Oncol. 2000, 16 (5): 1049-1054.
CAS
PubMed
Google Scholar
Karran L, Jones M, Morley G, van Noorden S, Smith P, Lampert I, Griffin BE: Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells. Int J Cancer. 1995, 60 (4): 562-566.
Article
CAS
PubMed
Google Scholar
Raife TJ, Lager DJ, Kemp JD, Dick FR: Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. Am J Clin Pathol. 1994, 101 (3): 296-299.
Article
CAS
PubMed
Google Scholar
Droz D, Zachar D, Charbit L, Gogusev J, Chretein Y, Iris L: Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol. 1990, 137 (4): 895-905.
CAS
PubMed
PubMed Central
Google Scholar
Figarella-Branger D, Moreau H, Pellissier JF, Bianco N, Rougon G: CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathol (Berl). 1993, 86 (3): 275-284. 10.1007/BF00304142.
Article
CAS
Google Scholar
Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P: CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood. 1997, 89 (9): 3385-3395.
CAS
PubMed
Google Scholar
Ablin RJ, Soanes WA, Bronson P, Witebsky E: Precipitating antigens of the normal human prostate. J Reprod Fertil. 1970, 22 (3): 573-574.
Article
CAS
PubMed
Google Scholar
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM: Delineation of prognostic biomarkers in prostate cancer. Nature. 2001, 412 (6849): 822-826. 10.1038/35090585.
Article
CAS
PubMed
Google Scholar
Halvorsen OJ, Oyan AM, Bo TH, Olsen S, Rostad K, Haukaas SA, Bakke AM, Marzolf B, Dimitrov K, Stordrange L, Lin B, Jonassen I, Hood L, Akslen LA, Kalland KH: Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation. Int J Oncol. 2005, 26 (2): 329-336.
CAS
PubMed
Google Scholar
Xu L, Tan AC, Naiman DQ, Geman D, Winslow RL: Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics. 2005, 21 (20): 3905-3911. 10.1093/bioinformatics/bti647.
Article
CAS
PubMed
Google Scholar
Calvo A, Gonzalez-Moreno O, Yoon CY, Huh JI, Desai K, Nguyen QT, Green JE: Prostate cancer and the genomic revolution: Advances using microarray analyses. Mutat Res. 2005, 576 (1–2): 66-79.
Article
CAS
PubMed
Google Scholar
Quinn DI, Henshall SM, Sutherland RL: Molecular markers of prostate cancer outcome. Eur J Cancer. 2005, 41 (6): 858-887. 10.1016/j.ejca.2004.12.035.
Article
CAS
PubMed
Google Scholar
Landers KA, Burger MJ, Tebay MA, Purdie DM, Scells B, Samaratunga H, Lavin MF, Gardiner RA: Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer. 2005, 114 (6): 950-956. 10.1002/ijc.20760.
Article
CAS
PubMed
Google Scholar
Kristiansen G, Denkert C, Schluns K, Dahl E, Pilarsky C, Hauptmann S: CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol. 2002, 161 (4): 1215-1221.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I: CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer. 2003, 88 (2): 231-236. 10.1038/sj.bjc.6600702.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M: CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res. 2003, 9 (13): 4906-4913.
CAS
PubMed
Google Scholar